Ototoxicity rates in children receiving carboplatin studied

February 29, 2012
Ototoxicity rates in children receiving carboplatin studied

(HealthDay) -- Retinoblastoma patients who are younger than 6 months of age at the start of carboplatin treatment experience a higher incidence of ototoxicity, according to a study published online Feb. 27 in the Journal of Clinical Oncology.

Ibrahim Qaddoumi, M.D., of the St. Jude Children's Research Hospital in Memphis, Tenn., and colleagues reviewed the results of audiologic tests for 60 patients with retinoblastoma who received front-line treatment with systemic carboplatin and vincristine according to either the St. Jude RET-3 protocol (23 patients) or best (37 patients). Three different ototoxicity grading systems were used.

The researchers found that 12 patients (20 percent) developed ototoxicity at some point following initiation of treatment; ototoxicity resolved in two patients, leaving 10 patients (17 percent) with sustained hearing loss. Nine of these 10 patients had grade 3 or 4 ototoxicity. Ninety percent of the 10 patients with hearing loss were less than 6 months of age at the start of chemotherapy. Age at the start of chemotherapy was the only risk factor that significantly predicted sustained hearing loss, and younger age was associated with an increased incidence of hearing loss. The different ototoxicity grading systems showed good overall agreement for identifying otoxicity, and agreement was greatest between the Brock and Children's Cancer Group systems.

"Young patients with who were treated with systemic had a higher incidence of ototoxicity than previously reported," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)
Editorial

Related Stories

Recommended for you

Single blood test screens for eight cancer types

January 18, 2018
Johns Hopkins Kimmel Cancer Center researchers developed a single blood test that screens for eight common cancer types and helps identify the location of the cancer.

How cancer metastasis happens: Researchers reveal a key mechanism

January 18, 2018
Cancer metastasis, the migration of cells from a primary tumor to form distant tumors in the body, can be triggered by a chronic leakage of DNA within tumor cells, according to a team led by Weill Cornell Medicine and Memorial ...

Researchers find a way to 'starve' cancer

January 18, 2018
Researchers at Vanderbilt University Medical Center (VUMC) have demonstrated for the first time that it is possible to starve a tumor and stop its growth with a newly discovered small compound that blocks uptake of the vital ...

Modular gene enhancer promotes leukemia and regulates effectiveness of chemotherapy

January 18, 2018
Every day, billions of new blood cells are generated in the bone marrow. The gene Myc is known to play an important role in this process, and is also known to play a role in cancer. Scientists from the German Cancer Research ...

These foods may up your odds for colon cancer

January 18, 2018
(HealthDay)—Chowing down on red meat, white bread and sugar-laden drinks might increase your long-term risk of colon cancer, a new study suggests.

The pill lowers ovarian cancer risk, even for smokers

January 18, 2018
(HealthDay)—It's known that use of the birth control pill is tied to lower odds for ovarian cancer, but new research shows the benefit extends to smokers or women who are obese.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.